← Back to headlines
Indian Generic Drugs Could Shake Up Global Weight Loss Market
In India, the patent for semaglutide – the active ingredient in Novo Nordisk's Wegovy and Ozempic – is expiring. Will this change the global landscape of obesity treatment?
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought
1h ago
Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer
4h ago
Cancer Survivor Erin Races Against Time for Chance of Motherhood
4h ago
West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia
9h ago